HomeNewsBusinessCRISIL withdraws SpiceJet's rating; puts company in non-cooperating category

CRISIL withdraws SpiceJet's rating; puts company in non-cooperating category

"Crisil Ratings is yet to receive adequate information from SpiceJet Limited (SpiceJet) to enable it to undertake a rating review. Crisil Ratings is taking all possible efforts to get the rated entity to cooperate with its rating process to enable it to carry out the rating review," the rating agency said.

November 02, 2021 / 20:00 IST
Story continues below Advertisement
A SpiceJet aircraft | Representative image
A SpiceJet aircraft | Representative image

Crisil Ratings has withdrawn its 'Crisil D' credit rating for SpiceJet Ltd stating that the airline has not provided it with adequate information to carry out a rating review, the international rating agency said in a press release.

"Crisil Ratings is yet to receive adequate information from SpiceJet Limited (SpiceJet) to enable it to undertake a rating review. Crisil Ratings is taking all possible efforts to get the rated entity to cooperate with its rating process to enable it to carry out the rating review," the rating agency said.

Story continues below Advertisement

In a statement to Moneycontrol, Spicejet has now clarified that it is no longer working with Crisil Ratings and hence is not obliged to provide any information. The rating agency currently reviewing Spicejet is Acute Ratings and Research Limited, whose rating has been accepted by the company's bank/lenders.

"The present ratings of the Company for its Bank Loan/Debt Instruments are- Long Term Instruments: BB- with stable outlook; Short Term Instruments: A4+. The Company had already advised the previous rating agency (i.e. Crisil) on July 13, 2020 about its intention to work with alternate rating agency to grade our investments, debt instruments and financing facility going forward. Accordingly, the Company is not obliged to provide any further update about the Company, as such to the previous rating agency. The new rating agency (i.e. Acute Ratings and Research Limited) has already been accepted by our lenders/banks, which has upgraded our ratings as above", read the statement.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show